Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Lymphoma and C1QA[original query] |
---|
A polymorphism in the complement component C1qA correlates with prolonged response following rituximab therapy of follicular lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Oct 14 (20): 6697-703. Racila Emilian, Link Brian K, Weng Wen-Kai, Witzig Thomas E, Ansell Stephen, Maurer Matthew J, Huang Jian, Dahle Christopher, Halwani Ahmad, Levy Ronald, Weiner George |
Homozygous FCGR3A-158V alleles predispose to late onset neutropenia after CHOP-R for diffuse large B-cell lymphoma. Internal medicine journal 2012 Oct 42 (10): 1113-9. Keane C, Nourse J P, Crooks P, Nguyen-Van D, Mutsando H, Mollee P, Lea R A, Gandhi M |
Identification of patients with indolent B cell lymphoma sensitive to rituximab monotherapy. Annals of hematology 2012 May 91 (5): 715-21. Cornec Divi, Tempescul Adrian, Querellou Solène, Hutin Pascal, Pers Jacques-Olivier, Jamin Christophe, Bendaoud Boutahar, Berthou Christian, Renaudineau Yves, Youinou Pier |
Homozygous A polymorphism of the complement C1qA276 correlates with prolonged overall survival in patients with diffuse large B cell lymphoma treated with R-CHOP. Journal of hematology & oncology 2012 5 (1): 51. Jin Xuan, Ding Huirong, Ding Ning, Fu Zhiying, Song Yuqin, Zhu J |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: